Does Rallies show 13F holders for CC?

Yes. Rallies tracks hedge fund and 13F ownership data for CC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CC. It does not provide personalized investment advice.

CC (The Chemours Company) Stock Analysis - Hedge Fund Holdings

The Chemours Company (CC) is a publicly traded Basic Materials sector company. As of May 21, 2026, CC trades at $22.34 with a market cap of $3.45B and a P/E ratio of 38.34. CC moved +2.30% today. Year to date, CC is +74.80%; over the trailing twelve months it is +99.37%. Its 52-week range spans $9.13 to $28.67. Analyst consensus is buy with an average price target of $25.67. Rallies surfaces CC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CC stock?

Hedge funds tracked by Rallies that own CC include Duquesne Family, Bridgewater Associates, Centerbook Partners, Soros Fund, and Pinebridge Investments. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for The Chemours Company.

CC Key Metrics

Key financial metrics for CC
Metric	Value
Price	$22.34
Market Cap	$3.45B
P/E Ratio	38.34
EPS	$0.58
Dividend Yield	0.09%
52-Week High	$28.67
52-Week Low	$9.13
Volume	1.43M
Avg Volume	0
Revenue (TTM)	$5.78B
Net Income	$86.00M
Gross Margin	19.91%

Top Hedge Funds Holding CC

Duquesne Family holds 421.80K shares of CC, changed +0.00% as of Jun 30, 2025.
Bridgewater Associates holds 149.26K shares of CC, changed -40.10% as of Mar 31, 2026.
Centerbook Partners holds 114.14K shares of CC, changed -54.20% as of Dec 31, 2024.
Soros Fund holds 112.35K shares of CC, changed +0.00% as of Mar 31, 2024.
Pinebridge Investments holds 62.11K shares of CC, changed +42.69% as of Dec 31, 2024.

Latest CC News

Chemours Study Projects 60%+ Cut in European Auto AC Emissions by 2050 — May 13, 2026
Chemours Q1 Loss of $29M, TSS Sales Rise 22% to $568M — May 5, 2026
Chemours (CC) jumps as earnings approach and Truist lifts target to $30 — Apr 30, 2026
Chemours jumps nearly 4% as shares hit fresh 52-week high ahead of May earnings — Apr 29, 2026
Chemours drops 3% as traders de-risk ahead of May 5 earnings after 52-week high — Apr 28, 2026

Recent CC Insider Trades

Dignam Denise bought 4.07K (~$49.06K) on Aug 8, 2025.
Gumpel Damian bought 7.82K (~$77.83K) on Jun 3, 2025.
Gumpel Damian bought 13.40K (~$123.55K) on Jun 2, 2025.

CC Analyst Consensus

9 analysts cover CC: 0 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.67.

Common questions about CC

Who owns CC stock?: Hedge funds tracked by Rallies that own CC include Duquesne Family, Bridgewater Associates, Centerbook Partners, Soros Fund, and Pinebridge Investments. The latest tracked quarter is Jun 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for The Chemours Company.
Does Rallies show 13F holders for CC?: Yes. Rallies tracks hedge fund and 13F ownership data for CC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CC. It does not provide personalized investment advice.